Trials / Completed
CompletedNCT00897884
Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Mount Sinai Hospital, Canada · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study will be testing metformin in patients with breast cancer who are about to undergo surgery. Patients will take metformin 3 times daily for about 2-3 weeks prior to their surgery date. It is hypothesized that metformin will reduce cell proliferation rates in tumour tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin | 500 mg tablet, taken 3 times a day for 2-3 weeks |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2009-05-12
- Last updated
- 2012-01-19
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00897884. Inclusion in this directory is not an endorsement.